Literature DB >> 2918671

Temporal patterns of cocaine use in pregnancy. Perinatal outcome.

I J Chasnoff1, D R Griffith, S MacGregor, K Dirkes, K A Burns.   

Abstract

Seventy-five cocaine-using women enrolled in a comprehensive perinatal care program were divided into two groups: those who used cocaine in only the first trimester of pregnancy (group 1 [N = 23]) and those who used cocaine throughout pregnancy (group 2 [N = 52]). Perinatal outcomes of these pregnancies were compared with perinatal outcomes of a matched group of obstetric patients with no history or evidence of substance abuse (group 3 [N = 40]). Group 2 women had an increased rate of preterm delivery and low-birth-weight infants as well as an increased rate of intrauterine growth retardation. Group 1 women had rates of these complications similar to the drug-free group. Mean birth weight, length, and head circumference for term infants were reduced in only the group 2 infants. However, both groups of cocaine-exposed infants demonstrated significant impairment of orientation, motor, and state regulation behaviors on the Neonatal Behavioral Assessment Scale.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918671

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  42 in total

Review 1.  The effects of maternal cocaine abuse on mothers and newborns.

Authors:  K Kaltenbach
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain.

Authors:  Deirdre M McCarthy; Xuan Zhang; Shayna B Darnell; Gavin R Sangrey; Yuchio Yanagawa; Ghazaleh Sadri-Vakili; Pradeep G Bhide
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

3.  A cohort study of the impact of perinatal drug use on prematurity in an inner-city population.

Authors:  J G Feldman; H L Minkoff; S McCalla; M Salwen
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

Review 4.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

5.  Improving screening for alcohol use during pregnancy: the Massachusetts ASAP program.

Authors:  Cheryl Kennedy; Norma Finkelstein; Ellen Hutchins; Jeanne Mahoney
Journal:  Matern Child Health J       Date:  2004-09

Review 6.  Perinatal effects of cocaine and amphetamine use during pregnancy.

Authors:  S R Kandall
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

7.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

8.  Neuropathological consequences of prenatal cocaine exposure in the mouse.

Authors:  Jia-Qian Ren; C J Malanga; Eddy Tabit; Barry E Kosofsky
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

9.  Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk.

Authors:  David S Bennett; Margaret Bendersky; Michael Lewis
Journal:  Dev Psychol       Date:  2002-09

10.  Independent and interactive associations of prenatal mood and substance use with infant birth outcomes.

Authors:  Marilyn Elizabeth Gyllstrom; Wendy L Hellerstedt; Patricia M McGovern
Journal:  Matern Child Health J       Date:  2011-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.